European Unified Registries for Heart Care Evaluation and Randomised Trials Italy
Trial Parameters
Brief Summary
Major advances in cardiovascular medicine have been driven by innovations in basic research in biological and technical sciences. Despite the clear evidence regarding the treatments that have been demonstrated to be useful to improve patients' outcomes, their transferability to everyday clinical practice seems to be at least suboptimal. The European Society of Cardiology (ESC), therefore, planned to support a program, denominated EuroHeart, for continuous data collection of standardized and/or harmonized variables in common cardiovascular diseases, such as ACS, HF and A Fib. EuroHeart is an observational, prospective, multicentre initiative with continuous data collection in consecutive patients with ACS, HF and A Fib to support continuous quality of care improvement through the evaluation of quality indicators (QIs) defined by the ESC. All patients included in the EuroHeart initiative, will enter a 12 month longitudinal follow-up with the collection of clinical events and clinical status data.
Eligibility Criteria
Inclusion Criteria: * Patients ≥18 years of age. * Males and females at birth. * At least one of the following clinical conditions: * Hospitalization for Acute Coronary Syndrome (ACS) * Heart failure (HF, outpatients, and/or inpatients) * Atrial fibrillation (A Fib, outpatients and/or inpatients) * Signed informed consent for the study and for privacy. Exclusion Criteria: * patients who do not sign the consent to participate in the project and/or Privacy